FLT1 and neoplasm: Preclinical and clinical evidence suggests an association between treatment with certain drugs (including 5-fluouracil, the drug most commonly used to treat advanced/metastatic pancreatic cancer) and increased levels of BM-derived EPC and VEGF-R1+ cells; these cells stimulate tumor progression and metastasis [54-56].